Advertisement

Sign up for our daily newsletter

Advertisement

Us preventive services task force obesity surgery: USPSTF Recommends Intensive Behavioral Intervention for Obesity

US Food and Drug Administration website.

Ethan Walker
Saturday, January 19, 2019
Advertisement
  • Create a free personal account to access your subscriptions, sign up for alerts, and more.

  • Prev Med.

  • One such trial could implement a systematic screening and treatment program in 1 set of clinics and providers and continue with usual care in a separate set of clinics and providers.

Blog Archive

Preventive Services Task Force. These interventions consisted of classroom-style sessions lasting 1 to 2 hours. Accessed May 26, The Asia Pacific perspective: Redefining obesity and its treatment.

Department of Health and Human Services. N Engl J Med. Although the remit of the recommendations lie within the US, they should be considered in the context of the global nature of obesity. Schuster DP. Prev Med.

Pooled reductions in systolic blood pressure 6 txsk pooled mean difference in change between groups, Analytic Framework. Sallis said patients also need to really focus on eating healthy foods. Voluntary and involuntary weight loss: associations with long-term mortality in 9, middle-aged and elderly men. Redefining obesity: beyond the numbers. Biological mechanisms that promote weight regain following weight loss in obese humans.

ODPHP has several resources that health care professionals can use in their interactions with patients to complement intensive multicomponent behavioral interventions:. Weight gain as a risk factor for clinical diabetes mellitus in women. Central adiposity increases the risk for cardiovascular and other diseases independent of obesity. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program.

Main navigation

While the benefit of surgical interventions was reviewed in the evidence summary for obesity screening and interventions, no recommendations were made. This recommendation updates the USPSTF recommendation statement on screening for obesity in children 6 years and older B recommendation. All participants had abnormal insulin or glucose metabolism.

Yaari S, Goldbourt U. Cell phone intervention for you CITY : a randomized, obeslty trial of behavioral weight loss intervention for young adults using mobile technology [published correction appears in Obesity Silver Spring. Adiposity and cancer at major anatomical sites: umbrella review of the literature. Lifestyle modification and weight reduction among low-income patients with the metabolic syndrome: the CHARMS randomized controlled trial. When this information was reported, participants were mostly white and of medium to high socioeconomic status.

J Am Coll Cardiol. Population inclusion criteria: Study was not conducted in an included population. Change in pain and physical function following bariatric surgery for severe obesity. Schuster DP. Risk of colorectal cancer after initiation of orlistat: matched cohort study.

Body Mass Index BMIwhich is simply weight adjusted for height, is a more practical xervices widely-used method to screen for obesity. In addition, all study participants completed more than two-thirds of the intervention. Long-term weight loss maintenance. Curr Atheroscler Rep. The USPSTF identified 89 behavior-based weight loss and weight loss maintenance trials, 26 of which were good quality and 63 of which were fair quality.

The USPSTF found adequate evidence to bound the harms of behavioral interventions as small to none and judged the harms of screening to be minimal. Diabetes Prevention Program Research Group. Copyright and Source Information. J Acad Nutr Diet.

The USPSTF has made recommendations on screening for abnormal blood glucose levels and type 2 diabetes, 13 screening for high blood pressure, 14 statin use in persons at risk for cardiovascular disease, 15 counseling for tobacco smoking cessation, 16 aspirin use in certain persons for prevention of cardiovascular disease, 17 and behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with and without common risk factors 1819 Table. The more narrowly defined inclusion criteria of these trials resulted in more selective populations enrolled as study participants. This recommendation updates the USPSTF recommendation statement on screening for obesity in children 6 years and older B recommendation. In contrast, NICE recommends considering surgery in obese class 3 individuals with other significant disease e. Figure 1.

Estimate of Magnitude of Net Benefit. Department of Health and Human Services. Sign in to save your search Sign in to your personal account. The USPSTF identified 89 behavior-based weight loss and weight loss maintenance trials, 26 of which were good quality and 63 of which were fair quality. Corresponding Author: David C.

Borrell LN, Samuel L. Some participants had large reductions in weight, some showed no or modest changes, and some continued to gain weight. The magnitude of this benefit is of uncertain clinical significance, because the evidence regarding the effectiveness of metformin and orlistat is inadequate. These recommendations represent an extension to the guidelines, highlighting the need for intensive counselling, rather than a major change in recommendation.

Trials used services task force delivery methods group, serviecs, mixed, and technology- or print-based. This work may not be reproduced, reprinted, or redistributed for a fee, nor may the work be sold for profit or incorporated into a profit-making venture without the express written permission of AHRQ. All significance testing was 2-sided, and results were considered statistically significant if the P value was 0. Screening for abnormal blood glucose and type 2 diabetes mellitus: U. Thus, the Task Force examined indirect evidence regarding the component questions of the effectiveness of interventions to lose weight, and the effects of weight loss on intermediate and clinical outcomes.

In the remaining trials, the differences between the intervention and control groups were not statistically significant. Pharmacological agents for weight loss have flrce potential harms, including anxiety, pancreatitis, and gastrointestinal symptoms with liraglutide; dizziness and cognitive impairment with lorcaserin; nausea, constipation, headache, and dry mouth with naltrexone and bupropion; cramps, flatus, fecal incontinence, and oily spotting with orlistat; and mood disorders, elevated heart rate, and metabolic acidosis with phentermine-topiramate. Although the diagnosis of obesity is at times obvious, clinicians often do not address the issue with their obese patients. Other intermediate outcomes were sparsely reported and showed mixed results. Gray DS, Fujioka K.

A recent randomised control trial identified a benefit of bariatric surgery plus uw therapy over medical therapy alone in glycaemic control in type 2 diabetes patients. Horm Res Paediatr. Bol Oficina Sanit Panam. Intervention harms were sparsely reported. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement.

Purchase access Subscribe to the journal. J Am Coll Cardiol. Trials are needed that examine whether interventions that focus on both weight loss and support of persons living with obesity improve patient-centered outcomes. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy Continue.

Main navigation

Another frequently raised concern was the lack of a recommendation for children younger than 6 years. Ann Epidemiol ;10 7 N Engl J Med.

  • With complex root causes and system-wide drivers of childhood obesity, clinical behavioral lifestyle interventions, while found effective during the follow-up period, are likely to address only proximal and short-term cognitive, behavioral, and informational factors that shape obesity.

  • Another frequently raised concern was the lack of a recommendation for children younger than 6 years. For studies of behavior-based interventions, it was required that controls have no intervention eg, wait list, usual care, assessment onlyminimal intervention eg, usual care limited to quarterly counseling sessions or generic brochuresor be attention controls eg, similar format and intensity but different content.

  • Author Contributions: Dr Grossman had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Other Considerations.

  • Behavior-based weight loss interventions with or without weight loss medications were associated with more weight loss and a lower risk of developing diabetes than control conditions.

  • Academy of Nutrition and Dietetics: standards of practice and standards of professional performance for registered dietitian nutritionists competent, proficient, and expert in adult weight management.

High rates of attrition, and a lack of post-continuation data were also identified as limitations to medication trials. However, the recommendation is limited by the lack of good quality evidence for the benefit of behavioural interventions on long-term health outcomes such as mortality, cardiovascular disease, and hospitalisation. Although NICE does acknowledge that orlistat is associated with some gastro-intestinal side-effects, these are considered mild and transient. Corresponding Author: David C. LeBlanc E. Articles from Annals of Medicine and Surgery are provided here courtesy of Elsevier. Screening and interventions for overweight in children and adolescents: recommendation statement.

Intensive interventions involving 52 or more contact hours rarely took place in primary care settings but rather in settings to which primary care clinicians could refer patients. Provenance and Peer Review. The USPSTF found adequate evidence to bound the harms of behavioral interventions as small to none and judged the harms of screening to be minimal. In addition, many studies could not be pooled due to insufficient reporting of variance data. Participants in behavior-based weight loss intervention groups demonstrated greater weight loss and decreased waist circumference compared with those in control groups at 24 months of follow-up. Quiz Ref ID Inthe USPSTF found that age- and sex-adjusted BMI calculated as weight in kilograms divided by the square of height in meters percentile is the accepted measure for detecting overweight or obesity in children and adolescents because it is feasible for use in primary care, a reliable measure, and associated with adult obesity.

Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. N Engl J Med. The search was between January 1,and June 6,building on the most recent full search for this topic.

Obes Res Clin Pract. Benefits for Health Outcomes Key Question 1. Adverse events of behavior-based interventions surgeyr sparsely reported, but no serious harms were related to interventions. The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis. Interventions that combined pharmacotherapy with behavioral interventions reported greater weight loss and weight loss maintenance over 12 to 18 months compared with behavioral interventions alone. Screening and interventions for overweight and obesity in adults: a summary of the evidence for the U.

No metformin trials reported health outcomes. Prevalence of childhood and adult obesity in the United States, The harms of behavioral interventions can be bounded as small to none, and the harms of screening are minimal. The National Academies Health and Medicine Division formerly the Institute of Medicine recommends that clinicians measure weight and length or height at every well-child visit using World Health Organization 0 to 23 months or CDC 24 to 59 months growth charts. Body-mass index and cause-specific mortality inadults: collaborative analyses of 57 prospective studies. The higher rate of adverse events in the medication groups resulted in higher dropout rates than in the placebo groups. Quiz Ref ID Obesity in children and adolescents is associated with morbidity such as mental health and psychological issues, asthma, obstructive sleep apnea, orthopedic problems, and adverse cardiovascular and metabolic outcomes eg, high blood pressure, abnormal lipid levels, and insulin resistance.

The USPSTF looked for evidence on potential harms of behavioral weight-loss interventions, including increased risk for fractures, serious injuries resulting from increased physical activity, and an increased risk for eating disorders, weight stigma, and weight fluctuation. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review.

In the trials not involving a primary care servjces, the interventionists were highly diverse and included behavioral therapists, psychologists, registered dietitians, exercise physiologists, lifestyle coaches, and other staff. Table 1. Are Asians at greater mortality risks for being overweight than Caucasians? J Clin Epidemiol ;44 6 CMAJ ; 4 All searches were limited to articles published in English. View Transcript.

ALSO READ: Ppar Gamma Antagonist Obesity In Children

Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. Get the latest information on the COVID vaccines to support your us preventive services task force obesity surgery, patients and community. The guideline setvices also found a lack of evidence regarding maintenance of weight loss after discontinuation of pharmacological treatment with orlistat, sibutramine, or metformin. Screening and interventions for overweight in children and adolescents: recommendation statement. Quiz Ref ID Obesity in children and adolescents is associated with morbidity such as mental health and psychological issues, asthma, obstructive sleep apnea, orthopedic problems, and adverse cardiovascular and metabolic outcomes eg, high blood pressure, abnormal lipid levels, and insulin resistance. Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement.

  • Sign in to make a comment Sign in to your personal account.

  • Arch Intern Med.

  • Endocr Pract.

  • Interventions that combined pharmacotherapy with behavioral interventions reported greater weight loss and weight loss maintenance over 12 to 18 months compared with behavioral interventions alone.

  • The review identified the following characteristics of effective intensive multicomponent behavioral interventions:.

Participants were aged 8 to 12 years at baseline mean age, Most of these interventions took place for more than 1 year and involved more than 12 sessions median, 23 total sessions in the first year. Schauer P. As overweight and obesity are shown to be more prevalent among racial and ethnic minorities and in disadvantaged communities, the effectiveness, access, and long-term outcomes of a clinic-based weight management approach remains a question. Other Considerations. Only 3 of the 24 trials with less than 26 contact hours showed statistically significant benefits of treatment.

In addition, obesity in childhood and adolescence often leads to obesity in adulthood, which leads to poor health outcomes. The USPSTF commissioned a systematic evidence review to update its recommendation on screening for obesity in adults. Half of trials represented an unselected population eligible for participation based on BMI; the remaining half recruited adults who were overweight or had obesity and at high cardiovascular risk prediabetes, hypertension, high-normal blood pressure, the metabolic syndrome. Maintenance of weight loss after initiation of nutrition training: a randomized trial. J Am Coll Nutr. Prev Med.

Pharmacotherapy-Based Weight Loss and Weight Loss Maintenance Interventions Pharmacological agents for weight loss have multiple potential harms, including anxiety, pancreatitis, and gastrointestinal symptoms with liraglutide; dizziness and cognitive impairment with lorcaserin; nausea, constipation, headache, and dry mouth with naltrexone and bupropion; cramps, flatus, fecal incontinence, and oily spotting with orlistat; and mood disorders, elevated heart rate, and metabolic acidosis with phentermine-topiramate. The Community Preventive Services Task Force recommends behavioral interventions to reduce sedentary screen time among children 13 years and younger. Provenance and Peer Review. Healthy People Final Review. When this information was reported, participants were mostly white and of medium to high socioeconomic status.

  • Author contributions Single author manuscript. Screening for high blood pressure in adults: U.

  • Across the trials, there were large standard deviations relative to the mean change, suggesting that some adults showed fairly large reductions in weight, some showed no or modest changes, and some gained weight. Studies tended to report mean group weight change and not frequency of response to the interventions.

  • High intensity behavioural intervention resulted in weight loss and a reduction in the incidence of diabetes, as well as improvement in glucose tolerance, blood pressure, and waist circumference.

  • J Occup Environ Med. The magnitude of these benefits is moderate.

  • Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. Contact Us.

Quiz Ref ID Inthe USPSTF found that age- and sex-adjusted BMI calculated as weight in kilograms divided by the square of height in meters percentile is weekly savings accepted measure for detecting overweight or obesity in children and adolescents because it is feasible for use in primary care, a reliable measure, and associated with adult obesity. Article Information. Health effects of overweight and obesity in countries over 25 years. Sign in to download free article PDFs Sign in to access your subscriptions Sign in to your personal account. The USPSTF recognizes the challenges that children and their families encounter in having limited access to effective, intensive behavioral interventions for obesity.

  • N Engl J Med.

  • Efficacy of a gender-tailored intervention to prevent weight regain in men over 3 years: a weight loss maintenance RCT. The USPSTF recognizes the challenges that children and their families encounter in having limited access to effective, intensive behavioral interventions for obesity.

  • This limits the applicability of the results to a general pediatric population with obesity. Google Scholar Crossref.

  • Future research is needed on factors eg, genetics or untreated medical or psychological conditions that ttask be barriers to weight loss during behavioral interventions. Thirty trials examined the harms of behavior-based weight loss and weight maintenance interventions, and 33 trials and two observational studies assessed the harms of pharmacotherapy-based weight loss and weight maintenance interventions.

They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U. AHRQ and the US Department of Health and Human Services cannot endorse, preveentive appear to endorse, derivative or excerpted materials, and they cannot be held liable for the content or use of adapted products that are incorporated on other Web sites. Additional components of the most effective interventions included being conducted in a specialty setting; targeting both children and their parents; helping parents and children engage in stimulus control eg, limiting access to tempting foods and limiting screen time ; and assisting participants in identifying goals, self-monitoring, and problem solving to accomplish their selected goals. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.

Study on lifestyle-intervention and impaired glucose tolerance Maastricht SLIM : design and screening results. The USPSTF found adequate evidence that screening and intensive behavioral interventions for obesity in children and adolescents 6 years and older can lead to improvements in weight status. To read the evidence summary in JAMAselect here. Childhood adiposity, adult adiposity, and cardiovascular risk factors. Am J Public Health. Nonetheless, the degree of weight reduction obtained with surgical intervention is consistently dramatic typically 20 kg or more.

Publications

Report The USPSTF recognizes the challenges that children and their families encounter in having limited access to effective, intensive behavioral interventions for obesity. Story Highlights.

Get the latest information on the COVID vaccines to support your practice, patients and community. The evidence for the effectiveness of interventions for weight loss among overweight adults, compared with obese adults, is limited. Johnson, M. Obes Res. In more than half of the trials 40 trialsparticipants came from an unselected population of adults who were overweight or had obesity. Members of the U. Although weight outcomes were less well reported beyond 12 months, weight loss remained significantly greater in intervention compared with control conditions in interventions lasting up to 36 months.

To better summarize the interventions, each intervention group was categorized according to the main mode of intervention delivery into the following groups: 1 group 41 groups in surgery trials2 individual 37 groups in 33 trials3 mixed 18 groups in 16 trials4 technology-based 22 groups in 20 trialsand 5 print-based 2 groups in 1 trial. Available at www. Tracy Orleans, Ph. The prevention and treatment of obesity. Sallis also recommended MyFitnessPal, a free app and website that tracks diet and exercise to determine optimal caloric intake and nutrients based on patients' goals. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the advanced framework for a new diagnosis of obesity as a chronic disease. Recent analyses estimate that direct costs of obesity account for 5.

Body-mass index and mortality among 1. The role of stigma in weight loss maintenance among U. These interventions consisted of classroom-style sessions lasting 1 to 2 hours. To task force widespread ;reventive, consideration, adoption, and implementation of USPSTF recommendations, AHRQ permits members of the public to reproduce, redistribute, publicly display, and incorporate USPSTF work into other materials provided that it is reproduced without any changes to the work of portions thereof, except as permitted as fair use under the US Copyright Act. This work may not be reproduced, reprinted, or redistributed for a fee, nor may the work be sold for profit or incorporated into a profit-making venture without the express written permission of AHRQ.

American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the advanced framework for a new diagnosis of obesity as a chronic disease. Arch Intern Med ; 2 Health care professionals can help patients learn to make healthy choices — and understand why nutrition and physical activity are important for their health. Preventive Services Task Force recommendation statement.

  • Children may experience low self-esteem, impaired quality of life, and teasing and bullying behaviors based on their weight.

  • Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death.

  • Periodic health examination, update: 1.

  • Various environmental and genetic factors play an important role in the development of obesity. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force.

  • Only 3 of the 24 trials with less than 26 contact hours showed statistically significant benefits of treatment.

These trials also had high attrition. The USPSTF examined 3 categories of weight loss prreventive and behavioral interventions using lifestyle change, pharmacotherapy, and surgery. Preventive Services Task Force. What evidence supports this recommendation? Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention.

Chapter Staff. In the weight loss maintenance trials, patient randomization occurred after prior weight loss. Time of contact in the interventions ranged from 0. Population inclusion criteria: Study was not conducted in an included population. However, these trials were smaller and shorter than the larger trials.

Introduction

Additional components of the most effective interventions included being conducted in a specialty setting; targeting both children and their parents; helping parents and children engage in stimulus control eg, limiting access to tempting foods and limiting screen time ; and assisting participants in identifying goals, self-monitoring, and problem solving to accomplish their selected goals. About AAFP. Two main recommendations were made based on the findings.

Lieu, M. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Interventionists varied across the trials, and interventions included varied interactions with a primary care clinician. Weight management is a priority for agencies across the federal government, state governments, communities, and the health care sector. Periodic Health Examinations. The reference lists of previously published reviews, meta-analyses, and primary studies were also examined to identify any potential studies for inclusion.

Surgery why he puts a strong focus on getting an obese patient who's been sedentary to begin exercising. In addition, orlistat is associated with moderate harms. The USPSTF commissioned a systematic evidence review to update its recommendation on screening for obesity in adults, reviewing evidence on interventions for weight loss or weight loss maintenance that can be provided in or referred from a primary care setting. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. The more narrowly defined inclusion criteria of these trials resulted in more selective populations enrolled as study participants. Evidence Synthesis No.

Acknowledgements

All trials were fair quality. Useful Resources. Childhood adiposity, adult adiposity, and cardiovascular risk factors. The USPSTF recommends that clinicians screen for obesity in children 6 years or older and offer or refer them to a comprehensive, intensive behavioral intervention B recommendation.

Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives. To read the recommendation statement in JAMA forcd, select here. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. Circulation ; 1 As to the benefits of group sessions in treating obesity, Sallis said Kaiser Permanente has offered them for a number of years and they seem to be a good jumping-off point.

Us preventive services task force obesity surgery, the scope of the recommendations should be extended. BMC Public Health. Thirty trials examined the harms of behavior-based weight loss and weight maintenance interventions, and 33 trials and two observational studies assessed the harms of pharmacotherapy-based weight loss and weight maintenance interventions. Children and adolescents may also experience teasing and bullying behaviors based on their weight. Cardiovascular and metabolic risk factors were reported less frequently in trials with fewer contact hours, and pooled results were not associated with improvements in blood pressure, lipid levels, or insulin or glucose levels. Provenance and Peer Review.

Other intermediate outcomes: 4 trials reported mixed results for use of lipid-lowering and antihypertensive medications, prevalence of the metabolic syndrome, and y CVD risk score. Primary care clinician involvement ranged from limited interactions with participants in interventions conducted by other practitioners or individuals ie, group-based interventions conducted by lifestyle coaches or registered dietitians to reinforcing intervention messages through brief counseling sessions. The degree of weight loss in the current review is slightly smaller but consistent in magnitude with the review on this topic. Lifestyle and year survival free of heart attack, stroke, and diabetes in middle-aged British men. Sixth, there was also a paucity of data on long-term health outcomes. Daughters and Mothers Against Breast Cancer DAMES : main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters. Behavior-based weight loss maintenance trials were designed to maintain weight loss by continuing dietary changes and physical activity.

Most weight loss maintenance interventions lasted for 12 to 18 months; the majority of interventions had more than 12 sessions in the first year. A few observational studies have addressed the question of what change in BMI z score or excess weight represents a clinically important change. Alexander Yao: moc. Recommendations in UK guidelines similarly demonstrate a general paucity in their ability to translate evidence appraisal into a detailed implementation strategy. Many trials required participants to demonstrate medication adherence, meet weight loss goals before enrollment, or both.

Most pharmacotherapy trials only followed up participants for 6 months. Article Information. Progress in the control of childhood obesity. Ann Intern Med.

JAMA ; 6 Revision 5. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U. Biological mechanisms that promote weight regain following weight loss in obese humans. Eff Health Care ;3 2

Body us preventive services task force obesity surgery index as a measure of body fatness in the elderly. Earn the most with our new CME Maximizer pass. The Eervices searched for evidence that weight loss can affect mortality, morbidity, mental health, and daily functioning, but found the evidence severely limited. Studies with high attrition were included because early discontinuation was likely a result of the intervention ie, adverse effects, lack of weight loss, time commitments and not necessarily design flaws. Trials with 52 contact hours or more often included supervised physical activity sessions, as did approximately half of the trials with 26 to 51 contact hours.

Research Needs and Gaps. Trials included children and adolescents aged 2 to 19 years; almost half of the trials were limited to elementary school—aged children 6 to 8 years, up to 12 years. About AAFP. Overall, the USPSTF retained its statement to issue a grade B recommendation on screening and treating obesity among children 6 years of age or older. Intermediate outcomes eg, prevalence of high blood pressure or the metabolic syndrome, use of cardiovascular disease medications, or estimated year risk of cardiovascular disease were seldom reported.

ALSO READ: Nursing Care Plan For Activity Intolerance Related To Obesity

Screening and Interventions for Obesity in Adults. Most interventions were y in duration, forrce more than one-third were group-based interventions. BMC Public Health. Among 11 RCTs evaluating high-intensity interventions, only 3 explicitly stated the location of the interventions: 2 were conducted in large research clinics and 1 was conducted in a primary physician's office. Screening and interventions for overweight and obesity in adults: a summary of the evidence for the U.

This is of particular importance because obesity obeskty childhood and adolescence may continue into adulthood and lead to poor health outcomes. Surgical interventions also affect outcome measures of important co-morbidities. Most pharmacotherapy trials only followed up participants for 6 months. J Pediatr. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the advanced framework for a new diagnosis of obesity as a chronic disease. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Am J Prev Med.

WRAP Ahern et al, The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. Trials with 52 contact hours or more often included supervised physical activity sessions, as did approximately half of the trials with 26 to 51 contact hours.

Setting: Study was not conducted in a country relevant to United States practice or not conducted in, recruited from, or feasible for primary care or a health system. When this information was reported, participants were mostly white and of medium to high socioeconomic status. J Pediatr. Comments from reviewers were presented to the USPSTF during its deliberation of the evidence and were considered in preparing the final evidence review.

J Obes. Maintenance of weight loss in overweight middle-aged women through the Internet. Family physician Robert Sallis, M. The magnitude of this benefit is of uncertain clinical significance, because the evidence regarding the effectiveness of metformin and orlistat is inadequate.

Diabetes Zervices Program Research Group. Possible labeling effects of diagnosis may occur. A brief intervention for weight control based on habit-formation theory delivered through primary care: results from a randomised controlled trial. Lifestyle modification and weight reduction among low-income patients with the metabolic syndrome: the CHARMS randomized controlled trial. Eighty-nine trials examined the effectiveness of behavior-based weight loss and weight seevices maintenance interventions, 2425272932,46474953555658, 737576,,,and 35 examined the effectiveness or harms of medication for weight loss and weight loss maintenance. Scope of Evidence Review The USPSTF commissioned a systematic evidence review to update its recommendation on screening for obesity in adults, reviewing evidence on interventions for weight loss or weight loss maintenance that can be provided in or referred from a primary care setting. Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives.

NICE guidelines suggest orlistat should only be considered when dietary, exercise, and behavioural prevntive have been attempted and evaluated. Rent this article from DeepDyve. Additionally, per commenters' requests, in the Discussion section, the USPSTF clarified why patients who are overweight but not obese weren't included in the final recommendation statement, expanded the description of harms of behavioral counseling interventions and pharmacotherapy, and added information on the limitations of pharmacotherapy trials. Weight gain as a risk factor for clinical diabetes mellitus in women.

  • The more narrowly defined inclusion criteria of these trials resulted in more selective populations enrolled as study participants.

  • In the 3 trials large enough to examine differences in musculoskeletal issues between groups, results were mixed. Although weight outcomes were less well reported beyond 12 months, weight loss remained significantly greater in intervention compared with control conditions in interventions lasting up to 36 months.

  • The age-adjusted prevalence of obesity is higher among non-Hispanic black

  • Reasons for exclusion: Aim: Study aim was not relevant.

  • Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Sallis said he also recommends his patients avoid bariatric surgery and weight control medications in most cases.

  • Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. JAMA Pediatr.

Applying to Family Medicine? Institute of Medicine. Preventive Services Task Force USPSTF posted a final recommendation statement and final evidence summary on behavioral weight loss obesity surgery to prevent obesity-related morbidity and mortality in adults. Identifying obesity in children and how to address it are important steps in helping children and families obtain the support they need. Therefore, the USPSTF concludes with moderate certainty that offering or referring adults with obesity to intensive behavioral interventions or behavior-based weight loss maintenance interventions has a moderate net benefit. View Transcript. The U.

  • Preventive Services Task Force recommendation statement. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than persons.

  • Preventive Services Task Force. Another frequently raised concern was the lack of a recommendation for children younger than 6 years.

  • Health Psychol.

  • Conflicts of interest No conflicts of interest have been declared by the author.

In a separate recommendation, the USPSTF concluded that there is insufficient evidence to assess the balance of benefits and harms of screening for primary hypertension in asymptomatic children and adolescents to prevent subsequent cardiovascular disease in childhood or adulthood I statement. Recommendations of Others. Sign in to download free article PDFs Sign in to access your subscriptions Sign in to your personal account. Curry, PhD; Michael J. Treatment and Implementation. Only 1 trial delivered its intervention through print-based tailored materials. Half of the trials were conducted in the United States; the rest were conducted in Europe, Israel, or Australia.

Screening for and Management of Obesity and Overweight in Suurgery. The comprehensive behavioral interventions involved 30 or more contact hours with the families. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Evidence Synthesis No. One such trial could implement a systematic screening and treatment program in 1 set of clinics and providers and continue with usual care in a separate set of clinics and providers. Published online Nov

The importance of obesity as a health problem in the United States is increasingly apparent. BMJ Open. Most of these interventions took place for more than 1 year and involved more than 12 sessions median, 23 total sessions in the first year.

  • Summary of Recommendation and Evidence.

  • The CDC recommends 26 separate community strategies to prevent obesity, such as promoting breastfeeding, promoting access to affordable healthy food and beverages, promoting healthy food and beverage choices, and fostering physical activity among children.

  • Many comments asked about the components of effective interventions.

  • Prevalence of childhood and adult obesity in the United States,

  • The USPSTF found adequate evidence that screening and intensive behavioral interventions for obesity in children and adolescents 6 years and older can lead to improvements in weight status. Many children and adolescents with obesity also experience bullying behaviors and negative psychosocial problems 3.

Adherence was reported inconsistently. Surgical weight servces interventions and nonsurgical weight loss devices eg, gastric balloons are considered to be outside the scope of the primary care setting. Surgical weight loss interventions and nonsurgical weight loss devices e. Learn More. Obesity can be categorized as class 1 BMI of Energy intake in weight-reduced humans. The USPSTF recommends that clinicians screen for obesity in children 6 years or older and offer or refer them to a comprehensive, intensive behavioral intervention B recommendation.

ALSO READ: Women S Obesity Clinic In Boston

Therefore, the USPSTF encourages clinicians to promote behavioral interventions as the primary effective intervention for weight loss in children and adolescents. Audio Author Interview Ann Intern Med. Some of the more deeply entrenched psychosocial and emotional aspects of childhood obesity, including food addiction, may not be well-addressed in the clinical context. JAMA Pediatr. Data on follow-up beyond 1 year were limited.

Wilson Hask. Please review our privacy policy. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Approximately two-thirds of the participants were girls. Specifically, the task force reviewed evidence on four types of interventions: behavior-based weight loss 80 trialsbehavior-based weight loss maintenance nine trialspharmacotherapy-based weight loss 32 trials and pharmacotherapy-based weight loss maintenance three trials. James P.

J Am Coll Cardiol. Assessment of Risk. In the remaining trials, the differences between the intervention and control groups were not statistically significant. Data on follow-up beyond 1 year were limited.

  • Additionally, the effects of ethnicity, sex, and age should be considered when formulating recommendations. Benefits of Early Detection and Treatment or Intervention.

  • Am J Clin Nutr.

  • B recommendation. The Community Guide website.

  • Although the effects in the less intensive trials were seldom statistically significant, intervention groups frequently showed greater average reductions in excess weight than control groups.

  • Defined as a BMI of equal to or greater than 30, obesity in the United States has increased from a prevalence of 13 percent to 27 percent in the adult population over the last 40 years, and the prevalence of overweight rose from 31 percent to 34 percent.

Google Scholar Crossref. Gastrointestinal adverse effects eg, nausea, vomiting, or diarrhea were common in servoces the intervention and placebo groups but not serious. Screening for abnormal blood glucose and type 2 diabetes mellitus: U. This is an important message, as there are currently few drugs available for teens or children, and those available have notable side effects or other issues that may prevent widespread use. No cases of lactic acidosis were reported.

References 1. National Heart Lung and Blood Institute. Harms of Early Detection and Treatment or Intervention. Advertising or implied endorsement for any commercial products or services is strictly prohibited. Participant characteristics were similar to those in the behavioral intervention trials. Patient Population Under Consideration This recommendation applies to adults 18 years or older.

The higher rate of adverse events in the medication groups resulted in higher dropout rates than in the placebo groups. Orlistat 60 mg reduces visceral adipose tissue: a week randomized, placebo-controlled, multicenter trial. Clinical Preventive Service Recommendation: obesity. Data from medication trials could not be pooled because of the small number of studies for each medication or variability in reporting between trials.

Expand All. Clinical Considerations. NICE systematic reviews on behavioural interventions and weight lossand metformin were relied on to cover the search window from the previous Sugrery guideline and the current review. Secondly, the scope of the recommendations should be extended. Harms of Behavioral Counseling Interventions The USPSTF found adequate evidence to bound the harms of intensive, multicomponent behavioral interventions ie, behavior-based weight loss and weight loss maintenance interventions in adults with obesity as small to none, based on the absence of reported harms in the evidence and the noninvasive nature of the interventions.

PubMed Google Scholar. The USPSTF found adequate evidence that comprehensive, intensive behavioral interventions in children and adolescents 6 years and older who have obesity can result in improvements in weight status for up to 12 months. In addition, participants in the metformin trials had abnormal insulin or glucose metabolism, and most had severe obesity. Early Childhood Obesity Prevention Policies. References 1. High rates of attrition, and a lack of post-continuation data were also identified as limitations to medication trials.

Prevention of type 2 diabetes mellitus by changes in obeskty among subjects with impaired glucose tolerance. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of prospective studies in four continents. Waste us preventive services task force obesity surgery waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. The long-term health effects of surgery for obesity are not well characterized. The US Food and Drug Administration FDA review documents for each included medication were examined to identify any additional studies not published in the primary literature. Correlates of health-related quality of life, psychological well-being, and eating self-regulation after successful weight loss maintenance.

Read more about:

Sidebar1?
Sidebar2?